Berry Genomics Co.,Ltd (SHE:000710)

China · Delayed Price · Currency is CNY

9.42

+0.21 (2.28%)

Nov 2, 2026, 3:04 PM CST

Berry Genomics Co.,Ltd Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	920.76	929.82	1,078	1,151	1,368	1,422
Revenue Growth	-2.17%	-13.76%	-6.36%	-15.83%	-3.81%	-7.67%
Gross Profit	368.36	373.7	474.44	483.16	546.15	594.43
Operating Income	-168.08	-174.6	-119.47	-198.84	-125.56	-46.41
Net Income	-246.75	-196.84	-192.43	-427.2	-248.93	-110.82
Earnings Per Share	-0.70	-0.56	-0.54	-1.21	-0.81	-0.31
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023
Intersegment Elimination	-7.66	-	-	-
Overseas	122.1	135.63	119.76	129.79
China	815.37	942.53	1,032	1,238
Total	929.82	1,078	1,151	1,368

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	203.32	382.33	400.1	352.01	338.07	421.7
Total Debt	256.05	273.15	160.28	303.58	348.17	399.3
Net Cash (Debt)	-52.73	109.18	239.82	48.43	-10.11	22.4
Net Cash Growth	-	-54.47%	395.21%	-	-	-91.81%
Net Cash Per Share	-0.15	0.31	0.68	0.14	-0.03	0.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-38.29	70.61	87.97	111.01	21.18	94.03
Capital Expenditures	-48.46	-75.68	-56.75	-55.1	-73.31	-336.69
Free Cash Flow	-86.75	-5.08	31.22	55.91	-52.13	-242.66
Free Cash Flow Growth	-	-	-44.16%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	40.01%	40.19%	44.01%	41.96%	39.92%	41.80%
Operating Margin	-18.25%	-18.78%	-11.08%	-17.27%	-9.18%	-3.26%
Pretax Margin	-25.88%	-20.39%	-15.84%	-39.38%	-20.20%	-8.46%
Profit Margin	-26.80%	-21.17%	-17.85%	-37.10%	-18.20%	-7.79%
FCF Margin	-9.42%	-0.55%	2.90%	4.86%	-3.81%	-17.06%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Forward PE	-	39.28	39.28	39.28	39.28	51.73
P/FCF Ratio	-	-	95.70	72.85	-	-
PS Ratio	3.54	4.29	2.77	3.54	2.95	4.78